14372-65-7Relevant articles and documents
Design, synthesis, and apoptosis-promoting effect evaluation of novel pyrazole with benzo[d]thiazole derivatives containing aminoguanidine units
Liu, Da Chuan,Gao, Mei Jia,Huo, Qiang,Ma, Tao,Wang, Ying,Wu, Cheng Zhu
, p. 829 - 837 (2019/04/03)
New pyrazole with benzo[d]thiazoles containing hydrazinecarboximidamide substituent was synthesised and evaluated for cytotoxicity and apoptotic activity using the MTT assay, flow cytometry, and Western blot analysis. Among the compounds studied, (E)-2-((1-(6-((4-fluorobenzyl)oxy)benzo[d]thiazol-2-yl)-3-phenyl-1H- pyrazol-4-yl)methylene) hydrazinecarboximidamide (8l) was potent, with IC50 values of 2.41 μM, 2.23 μM, 3.75 μM and 2.31 μM in vitro anti-proliferative activity testing against triple-negative breast cancer cell line MDA-MB-231, non-triple-negative breast cancer MCF-7 cells, and human hepatocarcinoma HepG2 cells, and SMMC-7721 cells, respectively. Especially, the activity against MDA-MB-231 was similar to that of Doxorubicin, which was used as a positive control in this study. Next, the Annexin V/PI flow cytometry assay was used at different concentrations of compound 8l to demonstrate that compound 81 induced apoptosis of MDA-MB-231 cells in a concentration-dependent manner. Finally, these results were further verified by Western blot analysis. Taken together, the results of this study revealed that compound 8l may be a potential anticancer compound play a significant role in the subsequent researches.
Synthesis and biological evaluation of novel benzothiazole derivatives as potential anticonvulsant agents
Liu, Da-Chuan,Zhang, Hong-Jian,Jin, Chun-Mei,Quan, Zhe-Shan
, (2016/04/20)
New benztriazoles with a mercapto-triazole and other heterocycle substituents were synthesized and evaluated for their anticonvulsant activity and neurotoxicity by using the maximal electroshock (MES), subcutaneous pentylenetetrazole (scPTZ), and rotarod neurotoxicity (TOX) tests. Among the compounds studied, compound 2-((1H-1,2,4-triazol-3-yl)thio)-N-(6-((3-fluorobenzyl) oxy)benzo[d]thiazol-2-yl)acetamide (5i) and 2-((1H-1,2,4-triazol-3-yl)thio)-N-(6-((4-fluorobenzyl)oxy) benzo[d] thiazol-2-yl)acetmide (5j) were the most potent, with an ED50 value of 50.8 mg/kg and 54.8 mg/kg in the MES test and 76.0 mg/kg and 52.8 mg/kg in the scPTZ seizures test, respectively. They also showed lower neurotoxicity and, therefore a higher protective index. In particular, compound 5j showed high protective index (PI) values of 8.96 in the MES test and 9.30 in the scPTZ test, which were better than those of the standard drugs used as positive controls in this study.
One-dimensional to three-dimensional electronic conduction in liquid crystalline mesophases
Tokunaga, Keiji,Takayashiki, Yukiko,Iino, Hiroaki,Hanna, Jun-Ichi
scheme or table, p. 250 - 258 (2010/06/15)
We have established the electronic conduction in the nematic phase of a small molecule of a 2-phenylbenzothiazole derivative, i.e., 2-(4'- octyloxyphenyl)-6-butoxybenzothiazole (8O-PBT-O4). This gives a new insight into the quest for the electronic conduction in liquid crystals, which was initiated by Kusabayashi and Labes in late 1960s and had succeeded over several decades, leading it to the end. In addition, it is clarified that the ionic conduction often observed in less ordered mesophases is induced with trace amounts of chemical impurities due to its low viscosity. The present result indicates that the charge carrier transport in the mesophase is electronic in its intrinsic nature irrespective of mesophases and molecular sizes, i.e., 1D-electronic conduction in columnar phase, 2D-electronic conduction in smectic mesophases, and 3D-electronic conduction in the nematic phase.
